Cyfair Clinical Research Center - ERN- PPDS

Houston, Texas 77375-6579

0 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus, SARS-CoV-2

Studies at this site

• A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age — Completed
• A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive — Completed